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Table 1. Pearson correlation coefficients
NTX-I CTX-II HA COMP
Classic TQOL
K-L 0-IV 0.265* 0.298* 0.302** 0.226*
JSN 0-3 0.229 0.229 0.430*** 0.297**
TQOL-Lite
K-L 0-IV 0.282* 0.321* 0.362*** 0.263*
JSN 0-3 0.267* 0.200 0.398*** 0.276**
*p < 0.05 (2-tailed test). **p < 0.01 level (2-tailed test). *p < 0.001 level (2-tailed
test).
Sum Severity of scores for hips and knees provided similar
results to the original TQOL assessment tool, and simplifying its
general use. The full TQOL assessment tool should, however,
be considered to evaluate biomarker correlations for maximal
accuracy in overall assessments.
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Purpose: In humans, one of the most promising biochemical
markers of cartilage degradation is the C-terminal crosslinked
telopeptide of type II collagen (CTX-II). The rabbit model of an-
terior cruciate ligament transaction (ACLT) is a valuable animal
model of osteoarthritis (OA). The aim of this study was to de-
scribe the changes of cartilage degradation by measuring type II
collagen degradation fragments (CTX-II) in the urine of rabbits in
this ACTL model of OA.
Methods: 2 experimental groups of New Zeland rabbits were
studied: ACLT (n=32) and sham operated rabbits (n=32). A
medial parapatellar approach was used allowing the transection
of the ACL under complete visualisation in the middle third of the
ligament with the stumps left in the joint. Sham surgery consisted
of a complete arthrotomy including full visualisation of the ACL
which was always checked as fully intact. This procedure was
performed on only the right knee. At 2, 4, 8 and 12 weeks after
surgery, 8 rabbits per experimental group were sacrificed.
A macroscopic grading was performed on the right and left knee
joints using the scheme of the International Cartilage Repair
Society. Specific areas and sums of areas of all joint sites were
analysed. For microscopic evaluation, 4 muem sections of the
central tibial plateaus were stained with H&E and Safranin O.
Histologic analysis was performed with a dedicated grading sys-
tem accounting for pathologic alterations of proteoglycan content,
matrix structure, cellularity, tidemark duplication, and osteophyte
formation, basically a modified Mankin scheme.
Urinary CTX-II was measured by ELISA in 24 hr urine samples,
which were obtained during the 24 hrs before surgery and again
during 24 hrs each sacrifice time points. Intra- and inter - assay
CV was below 10%. Data were corrected for creatinine excretion
measured by standard colorimetric assay.
Results: All animals (n = 64) were free of signs of infection
and had a normal postoperative course. Lesions advanced with
time following the ACLT: at 2 weeks after ACLT, macroscopically
visible lesions were only detected at the medial femoral site (p<
0.05). With time, lesion size increased and lesions appeared at
more joint sites. At 12 weeks after ACLT, medial and lateral tibiae
as well as both femoral condyles showed statistically significant
lesions. Histologic scores showed early OA after ACLT, when
compared with the unoperated contralateral side. Also, a statis-
tically significant difference was seen versus the sham surgery
group at the respective timepoints. In sham operated animals,
compared to pre-operated controls, urinary CTX-II did not signif-
icant changed during the first 8 weeks and then decreased by
65% (p=0.01) at12 weeks. In ACTL rabbits, there was a median
77% increased in CTX-II levels for weeks after surgery and then
values decreased.
Conclusions: In this ACLT-rabbit model, urinary CTX-II levels
peaked 4 weeks after surgery suggesting that it may be valuable
to monitor cartilage degradation in this model of OA.
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Purpose: The CTX II assay has been used to examine the type
II collagen telopeptide concentration in human synovial fluid,
explant media, and urine of rats and humans. These reports
demonstrate that CTX II may be one of the most beneficial
biomarkers for diagnosing, predicting and monitoring changes
that occur to the articular cartilage in osteoarthritis (OA) patients.
Based on these reports, it seems logical that the CTX II assay has
the potential to help diagnose, predict and monitor OA changes
in horses since the horse is a good translational model of OA for
biomarker evaluation. Type II collagen is well conserved across
species, and Nordic Bioscience Diagnostics has demonstrated
that the amino acid sequence of the CartiLaps® epitope is 100%
conserved across many species including the horse. Thus, the
CartiLaps® assay has the potential to be used successfully in
equine models of OA.
Methods: Serum Pre-Clinical Cartilaps® ELISAs (Nordic Bio-
science Diagnostics) were used for this validation study ac-
cording to manufacturer protocols. Internal quality control (QC)
samples were prepared using the highest concentration stan-
dard provided by the manufacturer (259.4 pg/ml). To create QC
samples, fresh synovial fluid (SF) was collected aseptically from
6 middle carpal and 6 radiocarpal joints from 3 normal horses.
The samples were pooled together for further processing and
analysis. Pooled samples were spiked with a known amount of
standard to create samples with high, medium and low levels
of CTX II. The QC samples were used to determine the pre-
cision, specificity, sensitivity, accuracy, linearity of dilution, and
stability of this assay with equine SF. To ensure that the as-
say could detect different biological activity, previously stored SF
samples were analyzed from normal rested (n=2) and treadmill
exercised horses (n=2), as well as those with naturally-occurring
osteochondral (OC) injuries (n=2).
Results: Reproducibility of the standard curve was evaluated
(n=6 plates) by computing mean optical density (OD) and percent
coefficient of variation (% CV) at each standard concentration.
The overall mean inter-assay CV of the standard OD values was
11.1% (range; 6.8-13.7%). Samples exhibited acceptable intra-
assay and inter-assay precision over 3 plates with an overall
mean CV of 5.2% (range; 0.3-18.8%) and 9.3% (range; 5.3-
13.2%), respectively. Parallelism of SF sample dilutions (1:2,
1:4, 1:8, and 1:10) was demonstrated when compared to the
standard curve (Figure 1).
Lowest detection limit of the assay was determined to be 6.6
pg/ml. Percent recovery was 64.2% for high, 79.4% for medium,
and 93.2% for low QC samples. Linearity of equine SF sample
dilutions (1:2, 1:4, 1:8, and 1:16), was demonstrated (Figure
